Oko kufuneka ukwazi malunga nale nkunkuma ye-citrus antioxidant
I-Hesperidin yi-bioflavonoid (uhlobo lwe-pigment plant kunye nemiphunga e-antioxidant kunye ne-anti-inflammatory effects) efunyenwe ngokukodwa kwiziqhamo ezingenasiphunga. Ii-oranges, iidipefruit, i-lemon, kunye ne-tangerines iqukethe i-hesperidin, kwaye ikhona kwakhona kwifom yokongeza.
Kutheni Abantu Basebenzisa?
I-Hesperidin kucatshangelwa ukuba inemiphumo emihle kwimithambo yegazi. Kuye kwanjengendlela yokwenza isisombululo esingokwemvelo ngenani leengxaki zempilo, kubandakanya ukunyuka , ukunyuka kwegazi, uxinzelelo lwegazi oluphezulu , ukutshisa okutshisa, i-hay fever, i-sinusitis, iimpawu ezinxulumene neenguqu ze-menopausal, i- premenstrual syndrome , kunye nemivilini ye-varicose .
I-Hesperidin kuthiwa ukuphucula ukujikeleza, ukunciphisa ukuvuvukala , nokunceda ukulwa nomhlaza.
Izinzuzo
Uphando ngemiphumo yempilo ye-hesperidin ayinakuphelelwa. Nangona kunjalo, kukho ubungqina bokuba i-hesperidin inokunikela ngezibonelelo ezithile. Nanku ukukhangela kwezinye iziphumo zophando eziphambili:
YeMpilo yeNtliziyo
Ukusetyenziswa kwezityalo ze-citrus kuye kwadityaniswa nomngcipheko omncinci wesifo senhliziyo. Izilingo ezininzi zeklinikhi ezihlola umphumo we-hesperidin kwiimpawu zentsholongwane yempilo ziye zavelisa iziphumo ezidibeneyo.
Ucwaningo olwenziwa ngo-2015 olupapashwe kwi- American Journal of Clinical Nutrition , umzekelo, uphando ngefuthe leiveki ezintandathu ze-hesperidin ukwongezelelwa kwimithambo yegazi kubantu abakhulu kakhulu. Nangona bekungekho utshintsho oluphawulekayo ekuhlanjululeni umlambo (uvavanyo olwenziwe ukulinganisa umzobo, okanye u-endothelial, umsebenzi) ngokubanzi, i-subset yabantu abane-endothelial enempilweni enempilo yayinefuthe elikhulu emva kokutya isidlo esinamafutha aphezulu xa kuthelekiswa nalabo bathatha i placebo.
Inqanaba elilodwa le-hesperidin lingahle linciphise amanqaku omngcipheko we-cardiovascular risk markers kumadoda kwimeko engxamisekileyo yesifo senhliziyo, ibonisa ukuba uphando olwenziwe ngo-2015 olupapashwe kwi-American Journal of Clinical Nutrition. Emva komthamo omnye we hesperidin kwijusi ye-orange okanye isongezelelo, akukho miphumo eyabonwa kwiimpawu zengozi yempilo (ezifana nomsebenzi wokuphela komsebenzi, uxinzelelo lwegazi, kunye nokuqina kobungozi).
Nangona kunjalo, ukusetyenziswa kwe-hesperidin rhoqo kunokunciphisa uxinzelelo lwegazi kwaye kuphuculwe umsebenzi wesitya segazi kubantu abakhulu kakhulu, kuphakamisa uphando olupapashwe kwi- American Journal of Clinical Nutrition ngo-2015. Emva kweeveki ezine zokusetyenziswa kwansuku ye-orange okanye isiphuzo se-hesperidin, uxinzelelo lwegazi lwe-diastolic lwaluphantsi kakhulu kwaye umsebenzi wokuphela (emva kokutya ukutya) wawuphuculwe kakhulu.
I-Hesperidin ibonisa isithembiso kubantu abaye bahlaselwa yintliziyo, bacebisa uphando olupapashwe kwiNcwadi ye-American College of Nutrition ngo-2015. Ukufunda, abantu abane-infarction ye-myocardial bathatha i-hesperidin okanye i-placebo kwiiveki ezine. Ekupheleni kokufunda, abo bathatha i-hesperidin beye banciphisa kakhulu amanqaku eminye yabamakishi abavuthayo.
IMpilo yeCognitive
Ukusetyenziswa kwerusi ye-orange e-citrus ye-citrus i-citrus i-citrus inokunceda inzuzo engqondweni yabantu abadala abadala, ngokutsho kwincwadana encinci epapashwe kwi- American Journal of Clinical Nutrition ngo-2015. Umsebenzi wokuqonda owenziwe ngcono kakhulu emva kweeyure ezisibhozo ukusetyenziswa kwejusi ecebileyo ye-bioflavonoid xa kuthelekiswa kwiiveki ezisibhozo zesiselo esiphantsi se-bioflavonoid.
AmaHemorrhoids
Ngophando luka-2015 kwi- Techniques kwiColoproctology , isongezelelo equkethe inhlanganisela ye-bioflavonoids (hesperidin, diosmin, kunye ne-troxerutin) yafunyanwa ekuncedeni unyango lwe-hemorrhoids. Ukufunda, abantu abangama-134 abaneengqungqungqungqungquthela zonyango baphathwa nge-hesperidin / diosmin / troxerutin inhlanganisela okanye indawo ye-placebo ezili-12 iintsuku.
Xa kuthelekiswa nalabo bathatha indawo ye-placebo, abantu abathatha i-bioflavonoids bafumana ukunciphisa kakhulu intlungu kunye nokuphuma. Umlinganiselo wabantu abavakalisa ukunyamezela ukukhukhumeza kunye ne-thrombosis kwancipha kakhulu. Emva kweentsuku ezithandathu, inani lezonyango zomlomo ezithatyathwa ngabantu abathatha i-bioflavonoids nazo ziphantsi.
Iimiphumo zangaphandle
I-Hesperidin ingabangela imiphumo emibini, kuquka intlungu yesisu, isifo sohudo , uxhumano lwe-dermatitis, kunye nesisulu.
I-Hesperidin isongezelelo ayinakukhuseleka kubantu abathatha imithi ethile (kuquka i-anticoagulants, izidakamizwa zegazi kunye ne-calcium channel blockers). Ngoko ke, kubalulekile ukubonisana nodokotela wakho ukuba ucinga ukusebenzisa i-hesperidin ngokudibanisa namanye amayeza.
Uphando lwezonyango lubonisa ukuba i-hesperidin inokuchaphazela ukugawula igazi kunye nokwandisa umngcipheko wokuphuma kwamanzi. Abantu bathatha imithi ye-anticoagulant / antiplatelet, abo baneentsholongwane zokuphaphaka, kunye nabantu kwiiveki ezimbini ngaphambi okanye emva kokuhlinzwa akufanele bathathe i-hesperidin.
Kwakukho ityala elixeliweyo le-thrombocytopenic purpura (isifo esingakhokelela ekuphumeni okulula okanye okugqithiseleyo okanye okuxhatshazwayo) ehambelana nokusetyenziswa kwezilwanyana ezimbini eziqukethe i-citrus bioflavonoids.
Izibonelelo azange zivavanywe ukhuseleko kwaye ngenxa yokuba izongezo zokutya zikhululekile kakhulu, umxholo weemveliso ezithile zingahluka kwizinto ezichaziweyo kwilebula yomkhiqizo. Kwakhona ugcine ukhumbule ukuba ukhuseleko lwezongezelelo kwabasetyhini abakhulelweyo, oomama abangabongikazi, abantwana kunye nalabo abanezifo zonyango okanye abo bathabatha imishanguzo ayilwanga. Unokufumana iingcebiso ekusebenziseni izongezo apha , kodwa gcina ukhumbule ukuba ukuzithobela imeko kwaye ukuphepha okanye ukulibazisa ukunakekelwa okuqhelekileyo kunokuba nemiphumo emibi.
I-Takeaway
Nangona ukwandisa ukutya kwakho kwezithelo zelitrus kunokufumana inzuzo ethile, akufanele kusetyenziswe njengenxalenye yonyango okanye indlela yokuphila enempilo. Ukuba usacinga ukuzama i-hesperidin, qiniseka ukuba uthetha nomncedisi wakho oyintloko wokunakekelwa kuqala ukujonga ubunzima kunye neengxaki kwaye uxoxe ukuba kulungile kuwe.
Imithombo:
> Giannini I, Amato A, Basso L, et al. I-flavonoids ingxube (i-diosmin, i-troxerutin, i-hesperidin) ekhatyweni kwesifo esiqhekezayo: isifo esilungeleleneyo, esingahleliyo, esinezimpumputhe. Tech Coloproctol. 2015 Juni; 19 (6): 339-45.
> Haidari F, Heybar H, Jalali MT, Ahmadi Engali K, Helli B, Shirbeigi E. Hesperidin ukwongezelela ihambelana nezimpendulo zokuvuvukala emva kwe-infarction ye-myocardial. J Am Coll Nutriti. 2015; 34 (3): 205-11.
> Kean RJ, uLamport DJ, uDodd GF, et al. Ukusetyenziswa okungapheliyo kwerusi ye-orange ye-flavanone ifumaneka ngeenzuzo zokuqonda: i-8-wk, i-rand-based, i-double-blind, test-controlled trial in adults in health. Am J Clin Nutrition. Ngo-2015 uMar; 101 (3): 506-14.
> Morand C, Dubray C, Milenkovic D, et al. I-Hesperidin inegalelo ekukhuselweni kwe-vascular of juice yerantshi: isifundo se-crossover esingenamsebenzi kumavavolontiya anempilo. Am J Clin Nutrition. NgoJan 2011; 93 (1): 73-80.
> Salden BN, Troost FJ, de Groot E, et al. Uvavanyo lwezonyango olungaphendulwanga ngoncedo lwe-hesperidin 2S kwiimveliso ze-cardiovascular biomarkers ezinobungakanani bomzimba. Am J Clin Nutrition. Ngo-2016 Dec; 104 (6): 1523-1533.
> Schär WAM, Curtis PJ, Hazim S, et al. I-flavanone e-orange-derived derivolites ne-phenolic metabolites ayithinteli kakhulu i-cardiovascular risk biomarkers: i-random, i-placebo-elawulwayo, i-crossover trial among men in risk of disease. Am J Clin Nutrition. Ngo-2015 ngoMeyi; 101 (5): 931-8.
Ukuziphendulela: Ulwazi oluqulethwe kule ndawo lujoliswe kwiinjongo zemfundo kuphela kwaye alithathi indawo yeengcebiso, ukuxilongwa okanye unyango ngumgqirha onelayisenisi. Akunakuthetha ukukhusela zonke iindlela zokulondoloza, ukusebenzisana kwezidakamizwa, iimeko kunye nemiphumo emibi. Kufuneka uncede unyango lwangonyango ngokukhawuleza kuyo nayiphi na imiba yempilo uze ubonane nodokotela wakho ngaphambi kokusebenzisa elinye iyeza okanye wenze utshintsho kwi-regimen yakho.